|
71 |
A physiologically based pharmacokinetic and pharmacodynamic (PBPK/PD) model of the histone deacetylase (HDAC) inhibitor vorinostat for pediatric and adult patients and its application for dose specification
Enthalten in Cancer chemotherapy and pharmacology Bd. 80, 7.10.2017, Nr. 5, date:11.2017: 1013-1026
|
|
|
|
72 |
A physiologically based pharmacokinetic (PBPK) parent-metabolite model of the chemotherapeutic zoptarelin doxorubicin—integration of in vitro results, Phase I and Phase II data and model application for drug–drug interaction potential analysis
Enthalten in Cancer chemotherapy and pharmacology Bd. 81, 4.12.2017, Nr. 2, date:2.2018: 291-304
|
|
|
|
73 |
Effect of an interprofessional care concept on the hospitalization of nursing home residents: study protocol for a cluster-randomized controlled trial
Enthalten in Trials Bd. 21, 18.5.2020, Nr. 1, date:12.2020: 1-11
|
|
|
|
74 |
Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions
Enthalten in Pharmaceutical research Bd. 37, 25.11.2020, Nr. 12, date:12.2020: 1-14
|
|
|
|
75 |
The feasibility of physiologically based pharmacokinetic modeling in forensic medicine illustrated by the example of morphine
Enthalten in International journal of legal medicine Bd. 132, 1.12.2017, Nr. 2, date:3.2018: 415-424
|
|
Administration
